Andrew E Horvai, MD
Pathology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 2
- Since medical school
- 28 years
- University of California, San Diego School of Medicine, 1998
Offices
2 locations · University of California San Francisco · 1,780 clinicians in this group
Hospitals listed: UCSF Health Stanyan Hospital · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Horvai’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A70479 · Current
Licensed to practise in California · since 1999 · expires 2027-12-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Pathology - Pathology – Anatomic
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$20,580
Medicare paid this office $20,580 for 198 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, moderately high complexity | 59 | $5,782 | $73 |
| Special stained specimen slides to examine tissue, each additional procedure | 39 | $5,253 | $25 |
| Pathology examination of tissue using a microscope, intermediate complexity | 66 | $3,293 | $33 |
| Special stained specimen slides to examine tissue, initial procedure | 46 | $1,524 | $31 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 17 | $1,052 | $62 |
See all 8 services
| Pathology examination of tissue using a microscope, moderately high complexity | 59 | $5,782 | $73 |
| Special stained specimen slides to examine tissue, each additional procedure | 39 | $5,253 | $25 |
| Pathology examination of tissue using a microscope, intermediate complexity | 66 | $3,293 | $33 |
| Special stained specimen slides to examine tissue, initial procedure | 46 | $1,524 | $31 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 17 | $1,052 | $62 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 12 | $943 | $79 |
| Pathology examination of tissue using a microscope, moderately low complexity | 30 | $382 | $10 |
| Pathology examination of tissue using a microscope | 18 | $121 | $6 |
Who their Medicare patients are
198 Original Medicare patients in 2024. Average age 72 · Under 65 16% · 85 and older 11% · Women 39% · Also on Medicaid 31% · Health risk score 2.84. Sicker patients than 9 in 10 peers; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 44% · Chronic kidney disease 43% · Coronary heart disease 37% · Cancer 34% · Depression 34% · Heart failure 28% · Atrial fibrillation 25% · COPD 19% · Stroke 12% · Dementia 10%.
The office billed $135,223, Medicare allowed $26,171 and paid $20,580; for 591 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 198 | 591 | 72 | 2.84 | $135,223 | $20,580 |
| 2023 | 258 | 871 | 72 | 2.11 | $246,582 | $35,491 |
| 2022 | 312 | 1,126 | 71 | 1.94 | $295,686 | $46,045 |
| 2021 | 304 | 1,006 | 71 | 1.91 | $295,479 | $44,811 |
| 2020 | 249 | 916 | 72 | 2.36 | $248,001 | $40,977 |
| 2019 | 358 | 1,237 | 71 | 2.50 | $309,505 | $53,401 |
| 2018 | 343 | 1,071 | 70 | 2.34 | $251,223 | $44,737 |
| 2017 | 384 | 1,152 | 70 | 1.91 | $300,648 | $53,919 |
| 2016 | 466 | 1,295 | 71 | 1.83 | $341,908 | $63,795 |
| 2015 | 415 | 1,406 | 70 | 1.91 | $696,105 | $63,769 |
| 2014 | 522 | 2,175 | 70 | 1.43 | $1,715,433 | $90,599 |
| 2013 | 417 | 1,744 | 71 | 1.40 | $1,302,770 | $75,883 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Pathology examination of tissue using a microscope, moderately high complexity | 81 | $9,062 | $73 |
| Special stained specimen slides to examine tissue, each additional procedure | 59 | $7,760 | $25 |
| Pathology examination of tissue using a microscope, intermediate complexity | 78 | $4,719 | $32 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 29 | $3,678 | $127 |
| Special stained specimen slides to examine tissue, initial procedure | 60 | $2,080 | $31 |
| Pathology examination of specimen during surgery, first tissue block | 12 | $1,810 | $57 |
| Pathology examination of tissue using a microscope, high complexity | 14 | $1,716 | $123 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 19 | $1,437 | $76 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 17 | $1,345 | $79 |
| Pathology examination of tissue using a microscope, moderately low complexity | 44 | $469 | $10 |
| Examination of archival tissue for genetic analysis | 13 | $229 | $18 |
2022: 13 services
| Pathology examination of tissue using a microscope, moderately high complexity | 107 | $13,371 | $73 |
| Pathology examination of tissue using a microscope, intermediate complexity | 123 | $8,349 | $33 |
| Special stained specimen slides to examine tissue, each additional procedure | 58 | $7,360 | $25 |
| Pathology examination of specimen during surgery, first tissue block | 31 | $3,433 | $56 |
| Pathology examination of tissue using a microscope, high complexity | 22 | $3,345 | $129 |
| Special stained specimen slides to examine tissue, initial procedure | 74 | $2,659 | $31 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 28 | $2,090 | $75 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 17 | $1,487 | $78 |
| Special stained specimen slides to identify organisms including interpretation and report | 11 | $637 | $24 |
| Pathology examination of tissue using a microscope, moderately low complexity | 51 | $611 | $10 |
| Microscopic genetic analysis of tumor, manual | 12 | $562 | $37 |
| Special stained specimen slides to examine tissue including interpretation and report | 15 | $227 | $11 |
| Pathology examination of tissue using a microscope | 16 | $98 | $6 |
2021: 12 services
| Pathology examination of tissue using a microscope, moderately high complexity | 88 | $9,750 | $73 |
| Pathology examination of tissue using a microscope, intermediate complexity | 114 | $7,169 | $34 |
| Special stained specimen slides to examine tissue, each additional procedure | 53 | $7,008 | $26 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 41 | $6,212 | $152 |
| Pathology examination of specimen during surgery, first tissue block | 18 | $3,147 | $57 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 38 | $2,754 | $72 |
| Pathology examination of tissue using a microscope, high complexity | 18 | $2,367 | $131 |
| Special stained specimen slides to examine tissue, initial procedure | 64 | $2,320 | $32 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 12 | $877 | $73 |
| Special stained specimen slides to identify organisms including interpretation and report | 12 | $662 | $25 |
| Pathology examination of tissue using a microscope, moderately low complexity | 31 | $345 | $10 |
| Special stained specimen slides to examine tissue including interpretation and report | 13 | $188 | $11 |
2020: 11 services
| Pathology examination of tissue using a microscope, moderately high complexity | 87 | $11,610 | $79 |
| Pathology examination of tissue using a microscope, intermediate complexity | 96 | $6,887 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 50 | $6,374 | $27 |
| Pathology examination of tissue using a microscope, high complexity | 25 | $3,908 | $140 |
| Pathology examination of specimen during surgery, first tissue block | 18 | $2,697 | $60 |
| Special stained specimen slides to examine tissue, initial procedure | 64 | $2,214 | $34 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 22 | $1,659 | $75 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 18 | $1,426 | $79 |
| Special stained specimen slides to identify organisms including interpretation and report | 11 | $878 | $23 |
| Pathology examination of tissue using a microscope, moderately low complexity | 47 | $567 | $10 |
| Pathology examination of tissue using a microscope | 11 | $64 | $6 |
2019: 12 services
| Pathology examination of tissue using a microscope, moderately high complexity | 120 | $15,201 | $79 |
| Pathology examination of tissue using a microscope, intermediate complexity | 157 | $12,574 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 52 | $7,637 | $27 |
| Pathology examination of specimen during surgery, first tissue block | 31 | $4,371 | $60 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 44 | $3,286 | $75 |
| Pathology examination of tissue using a microscope, high complexity | 21 | $3,221 | $140 |
| Special stained specimen slides to examine tissue, initial procedure | 71 | $2,857 | $33 |
| Pathology examination of tissue using a microscope, moderately low complexity | 64 | $803 | $10 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 11 | $749 | $68 |
| Genetic sequencing localization, initial procedure | 12 | $497 | $41 |
| Pathology examination of tissue using a microscope | 14 | $96 | $6 |
| Pathology examination of tissue using a microscope, limited examination | 15 | $58 | $4 |
2018: 12 services
| Pathology examination of tissue using a microscope, moderately high complexity | 104 | $12,995 | $79 |
| Pathology examination of tissue using a microscope, intermediate complexity | 148 | $10,095 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 48 | $5,984 | $27 |
| Pathology examination of specimen during surgery, first tissue block | 25 | $3,962 | $60 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 32 | $2,577 | $78 |
| Pathology examination of tissue using a microscope, high complexity | 16 | $2,527 | $140 |
| Special stained specimen slides to examine tissue, initial procedure | 59 | $2,141 | $33 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 18 | $1,545 | $81 |
| Pathology examination of tissue using a microscope, moderately low complexity | 79 | $1,102 | $10 |
| Special stained specimen slides to identify organisms including interpretation and report | 15 | $803 | $25 |
| Pathology examination of tissue using a microscope | 14 | $87 | $6 |
| Pathology examination of tissue using a microscope, limited examination | 11 | $45 | $4 |
2017: 12 services
| Pathology examination of tissue using a microscope, moderately high complexity | 100 | $13,118 | $79 |
| Pathology examination of tissue using a microscope, intermediate complexity | 170 | $12,617 | $34 |
| Pathology examination of specimen during surgery, first tissue block | 38 | $5,704 | $60 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 34 | $4,936 | $145 |
| Special stained specimen slides to examine tissue, each additional procedure | 48 | $4,674 | $27 |
| Pathology examination of tissue using a microscope, high complexity | 24 | $3,674 | $141 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 46 | $3,460 | $75 |
| Special stained specimen slides to examine tissue, initial procedure | 67 | $2,459 | $34 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 16 | $1,300 | $81 |
| Pathology examination of tissue using a microscope, moderately low complexity | 72 | $957 | $10 |
| Special stained specimen slides to examine tissue including interpretation and report | 11 | $146 | $11 |
| Pathology examination of tissue using a microscope | 11 | $54 | $4 |
2016: 13 services
| Pathology examination of tissue using a microscope, moderately high complexity | 144 | $20,655 | $79 |
| Pathology examination of tissue using a microscope, intermediate complexity | 182 | $12,511 | $35 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 39 | $5,595 | $143 |
| Special stained specimen slides to examine tissue, each additional procedure | 64 | $5,490 | $26 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 62 | $5,071 | $79 |
| Pathology examination of tissue using a microscope, high complexity | 24 | $3,697 | $142 |
| Pathology examination of specimen during surgery, first tissue block | 25 | $3,190 | $60 |
| Special stained specimen slides to examine tissue, initial procedure | 83 | $2,952 | $33 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 31 | $2,517 | $79 |
| Pathology examination of tissue using a microscope, moderately low complexity | 76 | $875 | $10 |
| Special stained specimen slides to identify organisms including interpretation and report | 14 | $542 | $26 |
| Pathology examination of tissue using a microscope | 16 | $115 | $7 |
| Pathology examination of tissue using a microscope, limited examination | 12 | $58 | $4 |
2015: 14 services
| Pathology examination of tissue using a microscope, moderately high complexity | 123 | $18,874 | $79 |
| Pathology examination of tissue using a microscope, intermediate complexity | 166 | $13,046 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 76 | $5,523 | $20 |
| Pathology examination of tissue using a microscope, high complexity | 32 | $5,024 | $140 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 26 | $4,225 | $163 |
| Special stained specimen slides to examine tissue, initial procedure | 101 | $4,166 | $34 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 51 | $3,908 | $77 |
| Pathology examination of specimen during surgery, first tissue block | 29 | $3,574 | $60 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 31 | $2,326 | $75 |
| Pathology examination of tissue using a microscope, moderately low complexity | 70 | $903 | $10 |
| Special stained specimen slides to identify organisms including interpretation and report | 20 | $662 | $25 |
| Special stained specimen slides to examine tissue including interpretation and report | 15 | $226 | $11 |
| Pathology examination of tissue using a microscope | 15 | $96 | $6 |
| Pathology examination of tissue using a microscope, limited examination | 15 | $54 | $4 |
2014: 13 services
| Pathology examination of tissue using a microscope, intermediate complexity | 266 | $36,713 | $33 |
| Pathology examination of tissue using a microscope, moderately high complexity | 146 | $19,553 | $76 |
| Pathology examination of specimen during surgery, first tissue block | 45 | $8,529 | $57 |
| Pathology examination of tissue using a microscope, high complexity | 52 | $7,377 | $134 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 78 | $5,666 | $71 |
| Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | 91 | $3,117 | $27 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 15 | $2,552 | $170 |
| Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure) | 54 | $2,284 | $11 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 26 | $1,968 | $76 |
| Special stained specimen slides to identify organisms including interpretation and report | 21 | $798 | $23 |
| Pathology examination of tissue using a microscope, moderately low complexity | 66 | $746 | $10 |
| Pathology examination of tissue using a microscope | 18 | $128 | $6 |
| Pathology examination of tissue using a microscope, limited examination | 13 | $55 | $4 |
2013: 11 services
| Pathology examination of tissue using a microscope, intermediate complexity | 212 | $27,963 | $33 |
| Pathology examination of tissue using a microscope, moderately high complexity | 106 | $12,438 | $74 |
| Special stained specimen slides to examine tissue, initial procedure | 77 | $10,916 | $38 |
| Pathology examination of specimen during surgery, first tissue block | 47 | $10,151 | $56 |
| Pathology examination of tissue using a microscope, high complexity | 35 | $4,919 | $129 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 65 | $4,782 | $74 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 20 | $1,549 | $74 |
| Pathology examination of tissue using a microscope, moderately low complexity | 42 | $585 | $10 |
| Special stained specimen slides to identify organisms including interpretation and report | 13 | $553 | $24 |
| Pathology examination of tissue using a microscope | 19 | $115 | $6 |
| Pathology examination of tissue using a microscope, limited examination | 17 | $66 | $4 |
Medicaid work
$5,412 in 2023
Medicaid paid $5,412 for 61 billed services this clinician did in 2023, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 26 | $3,262 |
| TISSUE EXAM BY PATHOLOGIST | 35 | $2,150 |
| 2023 | 61 | 2 | 17 | $5,412 |
| 2022 | 28 | 2 | 13 | $2,368 |
| 2021 | 13 | 1 | 13 | $840 |
| 2020 | 51 | 2 | 14 | $5,010 |
| 2019 | 50 | 2 | 14 | $4,769 |
| 2018 | 30 | 1 | 15 | $828 |
See the largest Medicaid services in earlier years
2022
| TISSUE EXAM BY PATHOLOGIST | 14 | $1,489 |
| TISSUE EXAM BY PATHOLOGIST | 14 | $879 |
2021
| TISSUE EXAM BY PATHOLOGIST | 13 | $840 |
2020
| TISSUE EXAM BY PATHOLOGIST | 21 | $2,635 |
| TISSUE EXAM BY PATHOLOGIST | 30 | $2,374 |
2019
| TISSUE EXAM BY PATHOLOGIST | 17 | $2,609 |
| TISSUE EXAM BY PATHOLOGIST | 33 | $2,160 |
2018
| TISSUE EXAM BY PATHOLOGIST | 30 | $828 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1891752309
- Licence
- CA A70479California A70479: Current · expires 2027-12-31
- Trained
- University of California, San Diego School of Medicine, 1998 · 28 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A704790
- Taxonomy
- Federal specialty code 207ZP0101X (207ZP0101X)
- Mailing address
- 1635 Divisadero St, Ste 625, Box 1821, San Francisco, CA, 94143
- NPI first listed
- 2006-04-27
- NPI last updated
- 2026-07-13
This is when the NPI record was last certified, not a medical board exam.